Renin-Angiotensin-Aldosterone System Inhibitors in COVID-19: A Review

Among the multiple uncertainties surrounding the novel coronavirus disease (COVID-19) pandemic, a research letter published in The Lancet implicated drugs that antagonize the renin-angiotensin-aldosterone system (RAAS) in an unfavorable prognosis of COVID-19. This report prompted investigations to i...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferrari, Filipe, Martins, Vítor Magnus, Fuchs, Flávio Danni, Stein, Ricardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Faculdade de Medicina / USP 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009081/
https://www.ncbi.nlm.nih.gov/pubmed/33852652
http://dx.doi.org/10.6061/clinics/2021/e2342

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009081/
https://www.ncbi.nlm.nih.gov/pubmed/33852652
http://dx.doi.org/10.6061/clinics/2021/e2342

Ejemplares similares